Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 10, 2014 - Issue 1
Submit an article Journal homepage
3,022
Views
83
CrossRef citations to date
0
Altmetric
Review

Allogeneic tumor cell vaccines

The promise and limitations in clinical trials

Sanjay Srivatsan Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA
,
Jaina M Patel Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA
,
Erica N Bozeman Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA
,
Imade E Imasuen Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA
,
Sara He Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA
,
Danielle Daniels Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA
&
Periasamy Selvaraj Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USACorrespondence[email protected]
 show all
Pages 52-63 | Received 30 Apr 2013, Accepted 23 Sep 2013, Published online: 24 Sep 2013

Citations (83)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Fang Huang, Jinjin Zhao, Yiting Wei, Zhifa Wen, Yue Zhang, Xuru Wang, Yanfei Shen, Li-xin Wang & Ning Pan. (2020) Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells. International Journal of Nanomedicine 15, pages 1021-1035.
Read now
Julie Charles, Laurence Chaperot, Dalil Hannani, Juliana Bruder Costa, Isabelle Templier, Sabiha Trabelsi, Hugo Gil, Anaick Moisan, Virginie Persoons, Harald Hegelhofer, Edith Schir, Jean-Louis Quesada, Christophe Mendoza, Caroline Aspord, Olivier Manches, Pierre G. Coulie, Amir Khammari, Brigitte Dreno, Marie-Thérèse Leccia & Joel Plumas. (2020) An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial. OncoImmunology 9:1.
Read now
Ertugrul Eryılmaz & Cengiz Canpolat. (2017) Novel agents for the treatment of childhood leukemia: an update. OncoTargets and Therapy 10, pages 3299-3306.
Read now
Erica N Bozeman, Sara He, Yalda Shafizadeh & Periasamy Selvaraj. (2016) Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12. Human Vaccines & Immunotherapeutics 12:2, pages 421-430.
Read now
Erika Rijavec, Federica Biello, Carlo Genova, Giulia Barletta, Claudia Maggioni, Maria Giovanna Dal Bello, Simona Coco, Anna Truini, Irene Vanni, Angela Alama, Sabrina Beltramini, Maria Attilia Grassi, Francesco Boccardo & Francesco Grossi. (2015) Belagenpumatucel-L for the treatment of non-small cell lung cancer. Expert Opinion on Biological Therapy 15:9, pages 1371-1379.
Read now
Samantha L Kurtz, Sruthi Ravindranathan & David A Zaharoff. (2014) Current status of autologous breast tumor cell-based vaccines. Expert Review of Vaccines 13:12, pages 1439-1445.
Read now

Articles from other publishers (77)

Nimeet Desai, Pratik Katare, Vaishali Makwana, Sagar Salave, Lalitkumar K. Vora & Jyotsnendu Giri. (2023) Tumor-derived systems as novel biomedical tools—turning the enemy into an ally. Biomaterials Research 27:1.
Crossref
Andrea S. Lukes, Scarlet Dial, Clint Dart & Jeffrey F. Peipert. (2023) Spherical Ball-Shaped Intrauterine Device Long-Acting Reversible Contraception: Post-marketing Pharmacovigilance Assessment. EMJ Reproductive Health, pages 2-10.
Crossref
Xiaolin Xu, Wencai Guan, Xiaolei Yu, Guoxiong Xu & Chenglong Wang. (2023) Non-interfacial self-assembly of synthetic protocells. Biomaterials Research 27:1.
Crossref
Xue Jiang, Jiaojiao Zhang, Pik Kwan Lo & Zhengwei Mao. (2023) Polyphenol‐Based Assembly Nanosystems as Multifunctional Biopharmaceutical Platform. Advanced NanoBiomed Research 3:6.
Crossref
Deepti Katiyar. (2023) Applications of intelligent biomaterials in cancer immunotherapy: A review. Materials Today: Proceedings.
Crossref
Hamed Hosseinalizadeh, Mohammad Rahmati, Ammar Ebrahimi & Roddy S. O'Connor. (2023) Current Status and Challenges of Vaccination Therapy for Glioblastoma. Molecular Cancer Therapeutics 22:4, pages 435-446.
Crossref
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, Navneet Singh, Purvish Parikh, Bharti Bisht, Anubhab Mukherjee & Manash K. Paul. (2023) Lung cancer immunotherapy: progress, pitfalls, and promises. Molecular Cancer 22:1.
Crossref
Shirong Tan. (2023) Cancer Immunotherapy: A Brief History, The Latest Development of Typical Subtypes and Therapy Combination. Highlights in Science, Engineering and Technology 30, pages 34-43.
Crossref
Mariam Oladejo, Wyatt Paulishak & Laurence Wood. (2023) Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines. Seminars in Cancer Biology 88, pages 81-95.
Crossref
Melissa Anne Tutty, Sarah Holmes & Adriele Prina-Mello. 2023. Cancer Cell Culture. Cancer Cell Culture 3 40 .
Hong Sung Kim. (2022) Anti-tumor Effect of 4-1BBL Modified Tumor Cells as Preventive and Therapeutic Vaccine. Biomedical Science Letters 28:4, pages 312-316.
Crossref
Chang Liu, Min Wang, Haiyang Zhang, Chunyan Li, Tianshou Zhang, Hong Liu, Song Zhu & Jie Chen. (2022) Tumor microenvironment and immunotherapy of oral cancer. European Journal of Medical Research 27:1.
Crossref
Lianru Zhang, Xipeng Zhou, Huizi Sha, Li Xie & Baorui Liu. (2022) Recent Progress on Therapeutic Vaccines for Breast Cancer. Frontiers in Oncology 12.
Crossref
Seyed Amir Sadeghi Najafabadi, Azam Bolhassani & Mohammad Reza Aghasadeghi. (2022) Tumor cell-based vaccine: an effective strategy for eradication of cancer cells. Immunotherapy 14:8, pages 639-654.
Crossref
Shengxian Li, Jing Wu, Xiaoping Li, Jingtao Chen & Chunxi Wang. (2022) Biomaterial-enhanced cancer vaccines. Materials & Design 218, pages 110720.
Crossref
Zhouqi Meng, Yaojia Zhang, Xuanfang Zhou, Jiansong Ji & Zhuang Liu. (2022) Nanovaccines with cell-derived components for cancer immunotherapy. Advanced Drug Delivery Reviews 182, pages 114107.
Crossref
Ling Peng, Zibing Wang, Justin Stebbing & Zhentao Yu. (2022) Novel immunotherapeutic drugs for the treatment of lung cancer. Current Opinion in Oncology 34:1, pages 89-94.
Crossref
Dixita Ishani Viswanath, Hsuan-Chen Liu, David P. Huston, Corrine Ying Xuan Chua & Alessandro Grattoni. (2022) Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 280, pages 121297.
Crossref
Víctor Chavarria, Rubén Figueroa, Aleli Salazar, Verónica Pérez de la Cruz & Benjamín Pineda. 2022. System Vaccinology. System Vaccinology 335 360 .
C. Alston James, Peter Ronning, Darren Cullinan, Kelsy C. Cotto, Erica K. Barnell, Katie M. Campbell, Zachary L. Skidmore, Dominic E. Sanford, S. Peter Goedegebuure, William E. Gillanders, Obi L. Griffith, William G. Hawkins & Malachi Griffith. (2021) In Silico Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines . Cancer Research Communications 1:2, pages 115-126.
Crossref
Tahseen H. Nasti & Christiane S. Eberhardt. (2021) Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy. Vaccines 9:12, pages 1396.
Crossref
Jimin Guo, Henning De May, Stefan Franco, Achraf Noureddine, Lien Tang, C. J. Brinker, Donna F. Kusewitt, Sarah F. Adams & Rita E. Serda. (2021) Cancer vaccines from cryogenically silicified tumour cells functionalized with pathogen-associated molecular patterns. Nature Biomedical Engineering 6:1, pages 19-31.
Crossref
Yacine Maringer & Juliane S. Walz. (2021) Tumorvakzinierung –Strategien und TimingTumor vaccination—strategies and time points. Der Internist 62:9, pages 991-997.
Crossref
Foon Ng Kee Kwong, Fiona Brodie, Claire McArthur & Fiona MacGregor. (2021) A Case Report: Internal Carotid Artery Dissection Presenting as Hoarseness Secondary to Vocal Cord Palsy. EMJ Neurology, pages 66-71.
Crossref
Taixia Wang, Xiaohong Xu & Kun Zhang. (2021) Nanotechnology-enabled Chemodynamic Therapy and Immunotherapy. Current Cancer Drug Targets 21:7, pages 545-557.
Crossref
Jun‐Long Liang, Guo‐Feng Luo, Wei‐Hai Chen & Xian‐Zheng Zhang. (2021) Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy. Advanced Materials 33:31.
Crossref
Rajesh Kumar Yadav, Bandana Kumari, Pritanjali Singh, Asgar Ali, Sadhana Sharma & Krishnan Hajela. 2021. Advances in Precision Medicine Oncology. Advances in Precision Medicine Oncology.
Yacine Maringer & Juliane S. Walz. (2021) Tumorvakzinierung –Strategien und TimingTumor vaccination—strategies and time points. Der Gastroenterologe 16:4, pages 241-248.
Crossref
Yuka Nakajima, Kenji Chamoto, Takuma Oura & Tasuku Honjo. (2021) Critical role of the CD44 low CD62L low CD8 + T cell subset in restoring antitumor immunity in aged mice . Proceedings of the National Academy of Sciences 118:23.
Crossref
Marzieh Naseri, Margot Zöller, Jamshid Hadjati, Roya Ghods, Ehsan Ranaei Pirmardan, Jafar Kiani, Leila Eini, Mahmood Bozorgmehr & Zahra Madjd. (2021) Dendritic cells loaded with exosomes derived from cancer stem cell‐enriched spheroids as a potential immunotherapeutic option. Journal of Cellular and Molecular Medicine 25:7, pages 3312-3326.
Crossref
Davis W. Crews, Jenna A. Dombroski & Michael R. King. (2021) Prophylactic Cancer Vaccines Engineered to Elicit Specific Adaptive Immune Response. Frontiers in Oncology 11.
Crossref
Tianlin Zhou, Jinrong Peng, Ying Hao, Kun Shi, Kai Zhou, Yun Yang, Chengli Yang, Xinlong He, Xinmian Chen & Zhiyong Qian. (2021) The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure. Bioactive Materials 6:3, pages 697-711.
Crossref
Zhuoya Wan, Ruohui Zheng, Pearl Moharil, Yuzhe Liu, Jing Chen, Runzi Sun, Xu Song & Qiang Ao. (2021) Polymeric Micelles in Cancer Immunotherapy. Molecules 26:5, pages 1220.
Crossref
Sandeep Pallerla, Ata ur Rahman Mohammed Abdul, Jill Comeau & Seetharama Jois. (2021) Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer. International Journal of Molecular Sciences 22:2, pages 779.
Crossref
Dujuan Cao, Qianqian Song, Junqi Li, Yuanyuan Jiang, Zhimin Wang & Shuangshuang Lu. (2021) Opportunities and challenges in targeted therapy and immunotherapy for pancreatic cancer. Expert Reviews in Molecular Medicine 23.
Crossref
Lucas Gutierrez, Nina S. Cauchon, Twinkle R. Christian, Michael J. Giffin & Michael J. Abernathy. (2020) The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations. Journal of Pharmaceutical Sciences 109:12, pages 3524-3534.
Crossref
Congshan Yuan, Ya Liu, Ting Wang, Mengjie Sun & Xiguang Chen. (2020) Nanomaterials as Smart Immunomodulator Delivery System for Enhanced Cancer Therapy. ACS Biomaterials Science & Engineering 6:9, pages 4774-4798.
Crossref
. (2020) Adaptations and Advancement of Biologic Immunotherapy in the Management of Immunologically Cold Solid Malignancies. EMJ Oncology.
Crossref
María Alejandra Gleisner, Cristián Pereda, Andrés Tittarelli, Mariela Navarrete, Camila Fuentes, Ignacio Ávalos, Fabian Tempio, Juan Pablo Araya, María Inés Becker, Fermín Eduardo González, Mercedes Natalia López & Flavio Salazar-Onfray. (2020) A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth. Journal for ImmunoTherapy of Cancer 8:2, pages e000999.
Crossref
Fan Yang, Kun Shi, Yan-peng Jia, Ying Hao, Jin-rong Peng & Zhi-yong Qian. (2020) Advanced biomaterials for cancer immunotherapy. Acta Pharmacologica Sinica 41:7, pages 911-927.
Crossref
Donia Alson, Scott C. Schuyler, Bo-Xin Yan, Karthika Samimuthu & Jiantai Timothy Qiu. (2020) Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model. Frontiers in Immunology 11.
Crossref
Ramireddy Bommireddy, Luis E. Munoz, Anita Kumari, Lei Huang, Yijian Fan, Lenore Monterroza, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Janet Kim, Zhuo G. Chen, Nabil F. Saba, Dong M. Shin & Periasamy Selvaraj. (2020) Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer. Vaccines 8:2, pages 182.
Crossref
Atefeh Arab, Rezvan Yazdian-Robati & Javad Behravan. (2020) HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development. Archivum Immunologiae et Therapiae Experimentalis 68:1.
Crossref
Shuangshuang Lu, Zhe Zhang, Pan Du, Louisa S. Chard, Wenli Yan, Margueritte El Khouri, Zhizhong Wang, Zhongxian Zhang, Yongchao Chu, Dongling Gao, Qinxian Zhang, Lirong Zhang, Ai Nagano, Jun Wang, Claude Chelala, Jing Liu, Jiekai Chen, Pentao Liu, Yunshu Dong, Shengdian Wang, Xiaozhu Li, Jianzeng Dong, Nick R. Lemoine, Duanqing Pei & Yaohe Wang. (2020) A Virus-Infected, Reprogrammed Somatic Cell–Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer. Clinical Cancer Research 26:2, pages 465-476.
Crossref
Manreet Randhawa & Robert Jones. (2020) Immunotherapy in Advanced Prostate Cancer. European Oncology & Haematology 16:1, pages 44.
Crossref
Hong Sung Kim. (2019) Development of Genetically Modified Tumor Cell Containing Co-stimulatory Molecule. Biomedical Science Letters 25:4, pages 398-406.
Crossref
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli & Chun-Wai Mai. (2019) Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
E. Krasniqi, G. Barchiesi, L. Pizzuti, M. Mazzotta, A. Venuti, M. Maugeri-Saccà, G. Sanguineti, G. Massimiani, D. Sergi, S. Carpano, P. Marchetti, S. Tomao, T. Gamucci, R. De Maria, F. Tomao, C. Natoli, N. Tinari, G. Ciliberto, M. Barba & P. Vici. (2019) Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives. Journal of Hematology & Oncology 12:1.
Crossref
Winfrey Pui Yee Hoo, Pui Yan Siak & Lionel L.A. In. (2019) Overview of Current Immunotherapies Targeting Mutated KRAS Cancers. Current Topics in Medicinal Chemistry 19:23, pages 2158-2175.
Crossref
Xiaoli Wang, Zuoguan Chen, Chao Zhang, Chuangnian Zhang, Guilei Ma, Jing Yang, Xiaoqing Wei & Hongfan Sun. (2019) A Generic Coordination Assembly‐Enabled Nanocoating of Individual Tumor Cells for Personalized Immunotherapy. Advanced Healthcare Materials 8:17, pages 1900474.
Crossref
Xiaoli Wang, Ning Wang, Ying Yang, Xiaoxiao Wang, Jiayi Liang, Xinxin Tian, Hailing Zhang & Xigang Leng. (2019) Polydopamine nanoparticles carrying tumor cell lysate as a potential vaccine for colorectal cancer immunotherapy. Biomaterials Science 7:7, pages 3062-3075.
Crossref
Birgit Ritter & Florian R. Greten. (2019) Modulating inflammation for cancer therapy. Journal of Experimental Medicine 216:6, pages 1234-1243.
Crossref
Veronika Caisova, Liping Li, Garima Gupta, Ivana Jochmanova, Abhishek Jha, Ondrej Uher, Thanh-Truc Huynh, Markku Miettinen, Ying Pang, Luma Abunimer, Gang Niu, Xiaoyuan Chen, Hans Kumar Ghayee, David Taïeb, Zhengping Zhuang, Jan Zenka & Karel Pacak. (2019) The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40. Cancers 11:5, pages 654.
Crossref
Rachel S. Riley, Carl H. June, Robert Langer & Michael J. Mitchell. (2019) Delivery technologies for cancer immunotherapy. Nature Reviews Drug Discovery 18:3, pages 175-196.
Crossref
Xiaoli Wang, Jiayi Liang, Chuangnian Zhang, Guilei Ma, Chun Wang & Deling Kong. (2019) Coordination microparticle vaccines engineered from tumor cell templates. Chemical Communications 55:11, pages 1568-1571.
Crossref
Mahsa Keshavarz-Fathi & Nima Rezaei. 2019. Vaccines for Cancer Immunotherapy. Vaccines for Cancer Immunotherapy 19 44 .
Rui Zhang, Margaret M. Billingsley & Michael J. Mitchell. (2018) Biomaterials for vaccine-based cancer immunotherapy. Journal of Controlled Release 292, pages 256-276.
Crossref
Daria Chulpanova, Valeriya Solovyeva, Kristina Kitaeva, Stephen Dunham, Svetlana Khaiboullina & Albert Rizvanov. (2018) Recombinant Viruses for Cancer Therapy. Biomedicines 6:4, pages 94.
Crossref
Markus D. Lacher, Gerhard Bauer, Brian Fury, Sanne Graeve, Emily L. Fledderman, Tye D. Petrie, Dane P. Coleal-Bergum, Tia Hackett, Nicholas H. Perotti, Ying Y. Kong, William W. Kwok, Joseph P. Wagner, Charles L. Wiseman & William V. Williams. (2018) SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4+ T Lymphocytes. Frontiers in Immunology 9.
Crossref
Nafiseh Pakravan & Zuhair Mohammad Hassan. (2018) Immunotherapy using regulatory T cells in cancer suggests more flavors of hypersensitivity type IV. Immunotherapy 10:3, pages 213-219.
Crossref
Adil Allahverdiyev, Gamze TariMelahat BagirovaEmrah Sefik Abamor. (2018) Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer. Journal of Breast Cancer 21:4, pages 343.
Crossref
R. Bryan Bell, Zipei Feng, Carlo B. Bifulco, Rom Leidner, Andrew Weinberg & Bernard A. Fox. 2018. Oral, Head and Neck Oncology and Reconstructive Surgery. Oral, Head and Neck Oncology and Reconstructive Surgery 314 340 .
Na Kyung Lee & Hong Sung Kim. (2017) Cancer Immunotherapy: Cancer Vaccines. Biomedical Science Letters 23:3, pages 161-165.
Crossref
Samuel C. Wagner, Thomas E. Ichim, Vladimir Bogin, Wei-Ping Min, Francisco Silva, Amit N. Patel & Santosh Kesari. (2017) Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine. Oncotarget 8:17, pages 28595-28613.
Crossref
Almohanad A. Alkayyal, Lee-Hwa Tai, Michael A. Kennedy, Christiano Tanese de Souza, Jiqing Zhang, Charles Lefebvre, Shalini Sahi, Abhirami A. Ananth, Ahmad Bakur Mahmoud, Andrew P. Makrigiannis, Greg O. Cron, Blair Macdonald, E. Celia Marginean, David F. Stojdl, John C. Bell & Rebecca C. Auer. (2017) NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine. Cancer Immunology Research 5:3, pages 211-221.
Crossref
Jan Aleksander Kraśko, Karolina Žilionytė, Adas Darinskas, Marius Strioga, Svetlana Rjabceva, Iosif Zalutsky, Marina Derevyanko, Vladimir Kulchitsky, Werner Lubitz, Pavol Kudela, Edita Miseikyte-Kaubriene, Olha Karaman, Hennadii Didenko, Hryhorii Potebnya, Vasyl Chekhun & Vita Pašukonienė. (2017) Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model. Oncology Reports 37:1, pages 171-178.
Crossref
Yuwen Zhu, Alessandro Paniccia, Barish H. Edil & Richard D. Schulick. 2017. Innovation of Diagnosis and Treatment for Pancreatic Cancer. Innovation of Diagnosis and Treatment for Pancreatic Cancer 225 241 .
Aryeh Keehn, Benjamin Gartrell & Mark P Schoenberg. (2016) Vesigenurtacel-L (HS-410) in the management of high-grade nonmuscle invasive bladder cancer. Future Oncology 12:23, pages 2673-2682.
Crossref
W-H Wang, C-H Zhou, J Ding, Y-X Zhang, L-L Zheng, S-F Chen & W Zhang. (2016) Immune effect and safety evaluation of vaccine prepared by dendritic cells modified by rAAV-carrying BCSG1 gene. Gene Therapy 23:12, pages 839-845.
Crossref
Alvaro Ortega-Carrion & Miguel Vicente-Manzanares. (2016) Concerning immune synapses: a spatiotemporal timeline. F1000Research 5, pages 418.
Crossref
Zipei Feng, Carlo B. Bifulco, Rom Leidner, R. Bryan Bell & Bernard A. Fox. 2016. Targeting Oral Cancer. Targeting Oral Cancer 211 224 .
Katherine Kunigelis & Michael Graner. (2015) The Dichotomy of Tumor Exosomes (TEX) in Cancer Immunity: Is It All in the ConTEXt?. Vaccines 3:4, pages 1019-1051.
Crossref
J. Convit, H. Montesinos, H. Oviedo, G. Romero, B. Maccarone, E. Essenfeld, A. Convit & L. E. Palacios. (2015) Autologous tumor lysate/Bacillus Calmette–Guérin immunotherapy as an adjuvant to conventional breast cancer therapy. Clinical and Translational Oncology 17:11, pages 884-887.
Crossref
Chien-Chiao Huang, Kung-Kai Kuo, Ta-Chun Cheng, Chih-Hung Chuang, Chien-Han Kao, Yuan-Chin Hsieh, Kuang-Hung Cheng, Jaw-Yuan Wang, Chiu-Min Cheng, Chien-Shu Chen & Tian-Lu Cheng. (2015) Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine. PLOS ONE 10:7, pages e0133470.
Crossref
Jaina M. Patel, Vincent F. Vartabedian, Min-Chul Kim, Sara He, Sang-Moo Kang & Periasamy Selvaraj. (2015) Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity. Biotechnology and Bioengineering 112:6, pages 1102-1110.
Crossref
Aurélien Lathuilière, Nicolas Mach & Bernard Schneider. (2015) Encapsulated Cellular Implants for Recombinant Protein Delivery and Therapeutic Modulation of the Immune System. International Journal of Molecular Sciences 16:12, pages 10578-10600.
Crossref
N. S. Prasanphanich, A. E. Luyai, X. Song, J. Heimburg-Molinaro, M. Mandalasi, M. Mickum, D. F. Smith, A. K. Nyame & R. D. Cummings. (2014) Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite. Glycobiology 24:7, pages 619-637.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.